| Size | Price | Stock |
|---|---|---|
| 1g | $12 | In-stock |
| 5g | $15 | In-stock |
| 10g | $18 | In-stock |
| 25g | $22 | In-stock |
| 100g | $36 | In-stock |
| 500g | $178 | In-stock |
| 1000g | $356 | In-stock |
| > 2 kg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-W018161 |
| M.Wt: | 286.41 |
| Formula: | C16H30O4 |
| Purity: | >98 % |
| Solubility: | DMSO : 100 mg/mL (ultrasonic) |
Hexadecanedioic acid (Thapsic acid) is an orally active metabolite produced by B. uniformis. Hexadecanedioic acid inhibits IRE1α-XBP1s-mediated flipogenesis and ferroptosis. Hexadecanedioic acid downregulates XBP1 and Hrd1 expression, activates the Nrf2/SLC7A11/GPX4 pathway. Hexadecanedioic acid can be used for the research of metabolic-associated fatty liver disease[1]. In Vitro:Hexadecanedioic acid (40-80 μg/mL; 24 h) reduces hepatic steatosis and inhibits ferroptosis in free fatty acid-induced HepG2 cells by downregulating XBP1 and Hrd1, and upregulating the Nrf2/SLC7A11/GPX4 pathway[1]. In Vivo:Hexadecanedioic acid (8-16 mg/0.2 mL; I.g.,; every other day; 12 weeks) ameliorates high-fat diet-induced Metabolic Associated Fatty Liver Disease (MAFLD) in male C57BL/6J mice in a dose-dependent manner[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.